Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (430)	12/6/2018 11:27:39 AM
From: scaram(o)uche	Read Replies (1) of 684

CLDX has continued down, is about to be (?) delisted. They have viable projects with agents where toxicity is believed to be a class effect. Similar to tgtx, the story is that their molecules are better. Just starting to take a look, nothing recommended in the least. Anybody else put a flashlight to them? Here's a list of active trials, sorry, but I am splitting for remainder of day...... clinicaltrials.gov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next